BIIB - BIOGEN INC.
IEX Last Trade
149.97
0.150 0.100%
Share volume: 6,488
Last Updated: Fri 27 Dec 2024 04:29:43 PM CET
Research and Development in Biotechnology (except Nanobiotechnology):
0.12%
PREVIOUS CLOSE
CHG
CHG%
$149.82
0.15
0.10%
View ratios
| Fiscal Date | 2022-09-30 | 2022-12-31 | 2023-03-31 | 2023-06-30 | 2023-09-30 | 2023-12-31 | 2024-03-31 | 2024-06-30 | |
|---|---|---|---|---|---|---|---|---|---|
| Fiscal Quarter | Q3 2022 | Q4 2022 | Q1 2023 | Q2 2023 | Q3 2023 | Q4 2023 | Q1 2024 | Q2 2024 | |
| Report Date | 2022-10-25 | 2023-02-15 | 2023-04-25 | 2023-07-25 | 2023-11-08 | 2024-02-14 | 2024-04-24 | 2024-08-01 | |
| Total revenue | 2.509 B | 2.544 B | 2.463 B | 2.456 B | 2.530 B | 2.386 B | 2.291 B | 2.465 B | |
| Cost of revenue | 469.500 M | 570.900 M | 662.800 M | 592.700 M | 659.600 M | 618.300 M | 542.200 M | 546.000 M | |
| Gross profit | 2.039 B | 1.973 B | 1.800 B | 1.863 B | 1.871 B | 1.768 B | 1.748 B | 1.919 B | |
| -3.23% | -8.76% | 3.51% | 0.40% | -5.49% | -1.11% | 9.76% | |||
| Operating expenses | 1.113 B | 1.234 B | 1.176 B | 1.132 B | 1.525 B | 1.179 B | 1.034 B | 1.068 B | |
| Selling general and admin | 563.300 M | 632.800 M | 605.000 M | 548.000 M | 788.200 M | 608.500 M | 581.500 M | 553.800 M | |
| Research and development | 549.200 M | 601.600 M | 570.600 M | 584.200 M | 736.300 M | 570.900 M | 452.900 M | 513.900 M | |
| Total expenses | 1.684 B | 1.935 B | 1.946 B | 1.835 B | 2.296 B | 1.929 B | 1.721 B | 1.763 B | |
| 14.92% | 0.55% | -5.70% | 25.12% | -15.98% | -10.79% | 2.47% | |||
| Operating income | 824.700 M | 609.000 M | 517.300 M | 621.300 M | 234.800 M | 457.700 M | 570.000 M | 701.900 M | |
| Ebit | 824.700 M | 528.500 M | 517.300 M | 621.300 M | 234.800 M | 457.700 M | 570.000 M | 701.900 M | |
| Pretax income | 1.371 B | 603.800 M | 438.300 M | 708.100 M | -141.200 M | 291.600 M | 464.800 M | 698.700 M | |
| -55.96% | -27.41% | 61.56% | -119.94% | -306.52% | 59.40% | 50.32% | |||
| Income tax | 236.200 M | 54.300 M | 50.700 M | 114.800 M | -72.900 M | 42.700 M | 71.400 M | 115.100 M | |
| Net income basic | 1.135 B | 550.400 M | 387.900 M | 591.600 M | -68.100 M | 249.700 M | 393.400 M | 583.600 M | |
| -51.49% | -29.52% | 52.51% | -111.51% | 466.67% | 57.55% | 48.35% | |||
| Net income | 1.135 B | 550.400 M | 387.900 M | 591.600 M | -68.100 M | 249.700 M | 393.400 M | 583.600 M | |
| -51.49% | -29.52% | 52.51% | -111.51% | 466.67% | 57.55% | 48.35% |